coagulopathies Flashcards

1
Q

name some hereditary primary bleeding disorders

A
  • vWD
  • qualitative platelet disorders (storage pool, Glanzmann, Bernard-Soulier)
  • congenital thrombocytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

name some acquired primary bleeding disorders

A
Medications
Uremia
Thrombocytopenia
Immune
Non-immune
Cardiac bypass
Myeloproliferative d/o
Acquired vWD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

name some hereditary secondary bleeding disorders

A

Hemophilia
Rare coagulation factor deficiencies
Fibrinolytic defects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

name some acquired secondary bleeding disorders

A
Liver disease
DIC
Vitamin K deficiency
Acquired coagulation factor inhibitors
Anticoagulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

acquired vessel wall bleeding disorders

A
  • vitamin C deficiency

- vascular trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

vWD inheritance pattern

A

autosomal dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

two functions of vWF

A
  • tethers platelets to collagen

- chaperones factor VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

quantitative types of vWD

A

1 and 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

qualitative types of vWD

A

2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

lab tests for vWD

A

coagulations screening

  • PT and TCT normal
  • aPTT possibly prolonged if factor VIII low
  • VIII low

platelet screening

  • prolonged PFA-100
  • prolonged bleeding time
  • abnormal aggregation with ristocetin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

treatment for vWD

A
  • DDAVP (for type 1 and some type 2)
  • vWF replacement (cryoprecipitate, alphate)
  • antifibrinolytic therapy
  • birth control for menorrhagia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is DDAVP and what does it do?

A

desmopressin, synthetic vasopressin

stimulates release of vWF and VIII from endothelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

when avoid DDAVP in treatment of vWD?

A

type 2B, exacerbates bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

deficiency in hemo A?

A

VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

deficiency in hemo B?

A

IX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

inheritance patterns of hemophilia

A
  • A and B are x-linked recessive

- C, parahemophilia are autosomal recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

deficiency of hemo C?

A

XI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

deficiency of parahemophilia?

19
Q

what is common in the female carrier state of hemophilia?

A

menorrhagia

20
Q

what are considered mild, moderate and severe for hemophilia A and B?

A

mild = 5-40% of factor level
moderate = 1-5% of factor level
severe = <1% of factor level
normal factor level is 50-150%

21
Q

expected labs in hemophilia A and B

A
  • platelet function normal
  • PT normal
  • prolonged aPTT except possibly in mild
  • aPTT will correct with mixing study
  • low specific factor levels
22
Q

bleeding manifestations in hemophilia?

A
  • may be delayed because primary still happens
  • bleeding into joints
  • CNS
  • bleeding after minor trauma
  • hematuria
23
Q

pathological issue with hemophilia

A

no thrombin burst with no IX or VIII

24
Q

hemophilia treatment

A
  • recombinant IX and VIII, replacing plasma derived
  • DDAVP sometimes effective in mild hemophilia
  • factors can be used prophylactically in severe hemophiliacs to keep factor level above 1%
25
complications of hemophilia
- chronic arthropathy - infectious diseases - development of antibodies against missing factor (might have to bypass using VIIa)
26
explain acquired hemophilia
- spontaneous autoantibody to factor VIII | - most are idiopathic
27
labs in acquired hemophilia
- platelets and PT normal - aPTT prolonged - aPTT will not correct with mixing study - low factor VIII
28
treatment of acquired hemophilia
- low antibody titer, treat with factor VIII - high antibody titer, treat with bypass agent (recombinant VII or FEIBA which includes II, VII, IX, X) - eradication by immune suppression
29
characteristics of fibrinolytic bleeding
- delayed 12-24 hours - mucocutaneous/oropharyngeal - menorrhagia, GU
30
is hereditary or acquired fibrinolytic bleeding more common?
acquired
31
explain hereditary fibrinolytic bleeding
- autosomal recessive - deficiency in alpha-2-antiplasmin or PAI-1, leaving more plasmin to break down fibrin - over expression of plasminogen activator (Quebec platelet disorder)
32
labs in fibrinolytic bleeding
- PT and PTT may be prolonged because fibrin is being broken down - hard to distinguish from DIC - increased products of fibrin breakdown (d-dimers)
33
treatment for fibrinolytic bleeding
- plasma infusions - anti-fibrinolytic drugs (if no DIC) - Amicar - tranexamic acid
34
what is the most common cause of bleeding due to vitamin K deficiency?
over anticoagulation with warfarin
35
causes of vitamin K deficiency
- dietary (malabsorption, alcoholism) - medications - coumarins (warfarin)
36
labs in vitamin K deficiency
- PT and aPTT prolonged (PT only in early deficiency) - PT and aPTT will correct with mixing study - platelets normal - decreased II, VII, IX, X - FACTOR V NORMAL!
37
treatment of vitamin K deficiency
- oral or IV vitamin K (corrects in hours) - fresh frozen plasm (only in emergencies, corrects factors immediately, must be used with vitamin K) - prothrombin complex concentrates (II, VII, IX, X)
38
what is preserved in liver failure?
factor VIII
39
what does liver disease look like for bleeding?
- both bleeders and clotters, but bleeding usually wins out
40
lab findings in coagulopathy of liver disease
- prolonged PT/INR and aPTT - low factors in INCLUDING V, but VIII is still preserved - PT/INR is unreliable
41
liver disease treatment
- transplant | - vitamin K and fresh frozen plasma can be temporary fixes
42
DIC - major relevant pathology for bleeding
- excessive thrombin, increases fibrin and activates platelets - compensatory increase in APC, plasmin, and fibrinolysis - increased activation of endothelium, more TF, more coagulation
43
labs in DIC
- prolonged PT/INR and aPTT - elevated d-dimers - low platelets - low fibrinogen - anemia - RBC schistocytes - low AT, APC, S
44
treatment for DIC
- treat underlying cause - transfusion support plasma (coagulation factors) cryoprecipitate (fibrinogen) platelets/RBC - heparin (only in active thrombosis)